Documents
Document Collection 299 total
| Document ID | Title | Source URL | Type | Auto Tags | Date | Actions | |
|---|---|---|---|---|---|---|---|
8f9fe853...
|
Biogen and Dayra Therapeutics Announce Research Co... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-11-24 | ||
0f80b4f6...
|
Biogen Initiates Phase 3 Pediatric Study of Omavel... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-06-18 | ||
d2971408...
|
Biogen Inc. Earnings Call Q4 2024 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2024-12-28 | ||
7d9d4252...
|
Biogen Inc. Earnings Call Q2 2024 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2024-06-28 | ||
e1d39e77...
|
Biogen to Advance Investigational Spinal Muscular ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-06-25 | ||
c3291789...
|
Biogen Enters into Agreement with TJ Biopharma for... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-04-20 | ||
9a395fb4...
|
Biogen to Present Additional Results from Phase 3 ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-10-22 | ||
4fb0da8d...
|
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subc... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-08-29 | ||
55c879d8...
|
Biogen Initiates Phase 3 Study of Felzartamab for ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-06-30 | ||
7e8b4cc4...
|
Anaptys Completes Separation of First Tracks Bioth... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-04-20 | ||
e4eff664...
|
GSK plc Earnings Call Q3 2025 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-09-28 | ||
a8fc8c1a...
|
Biogen and Stoke Therapeutics Announce Publication... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-11-17 | ||
254e2cb6...
|
Vertex Pharmaceuticals Incorporated Earnings Call ... | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-09-28 | ||
b3ca816b...
|
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoi... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-10-13 | ||
2b51062f...
|
Samsung Bioepis to Commercialize BYOOVIZ® (ranibiz... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-10-29 | ||
559bfce4...
|
Biogen Inc. Earnings Call Q2 2025 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-06-28 | ||
a5ac1228...
|
FDA Approves New High Dose Regimen of SPINRAZA® (n... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-03-30 | ||
90780365...
|
Health Canada Grants Authorization for “LEQEMBI®” ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-10-26 | ||
592b7d15...
|
Stoke Therapeutics and Biogen Announce Presentatio... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-08-25 | ||
b9db0522...
|
Novartis to add radioligand therapy manufacturing... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-01-09 |
Showing 81 to 100 of 299 documents